Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis. (Q45004690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Takayanagui OM

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mateus FH

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

520-525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

Therapy for neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Current consensus guidelines for treatment of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Small intestinal sulphoxidation of Albendazole

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Species differences in the generation of the chiral sulfoxide metabolite of albendazole in sheep and rats

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Increased systemic availability of albendazole when taken with a fatty meal

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Therapy for Neurocysticercosis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Quantitative determination of albendazole and its main metabolites in plasma

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Pharmacokinetics of albendazole in man

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.20071

7 January 2021

Identifiers

DOI

10.1002/CHIR.20071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15290687%20AND%20SRC:MED&resulttype=core&format=json

release_ogbxrs26xnbfxp7oyr25b37scm

31 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ogbxrs26xnbfxp7oyr25b37scm

24 November 2022

mapped directly with Wikidata item

1 reference